Hi All,

ISMP recommends the following regarding labeling in their 2022 Guidelines for
Safe Medication Use in Perioperative and Procedural Settings:

*Label containers (e.g., syringes, bowls, cups, basins) with medications and solutions (e.g., lidocaine, contrast, methylene blue, thrombin) on the STERILE FIELD immediately after filling... Never label an empty syringe, basin, cup, or other container in anticipation of use.*

I think that this is an excellent goal, and I'm curious to hear from others what strategies they used to accomplish this.

Can anybody be share an organizational structure/process that has worked well for you to have adequate oversight of your smart pumps-
Ranging from keeping up to date contracts, IT components such as wireless certificates, current versions etc.
We do a good job of library management but it’s the other pieces that seem to lapse or fall between the cracks.
Who manages this and what structure do you
have in place to stay up to date with everything?

Thanks so much!

Hello, I wanted to survey practices done at different institutions’ ophthalmology clinics to optimize our clinic’s practice from a medication safety perspective.

1. How are orders placed/communicated to the clinic staff from providers? (How do nurses/eye clinic staff know what medications to give)

2. Are providers placing orders through the electronic health system (ex., Order Sets)?
a) If so, what are some examples of medications your providers place through
the electronic health system?
b) If not, how are they communicating orders?

Are you using heparin or saline flush for IV lines? We are updating our policy for flushing IV lines and finding it difficult to obtain consensus on primary flush. Studies favor saline over heparin but not enough to provide definitive recommendations. We are also having difficulty finding data on volume and frequency to maintain patency. Would anyone be willing to share their policy?

Our institution has traditionally tested compounders in every individual location (Main pharmacy cleanroom, OR satellite, Cancer pharmacy cleanroom, etc.) My question: is this the practice at your facility?

Hello,

Our health system owns urology clinics that are compounding BCG in their offices. With the rollout of USP 800 we are working to try and give them practice guidance.

How does your system or physician offices handle BCG compounding? If you could share any polices or SOPs you have on this topic that would be appreciated.

Thank you,

Miheret Tesfaye
Medicaiton Safety Officer
Wellstar Health System

Has anoyone seen an increase in anaphylaxis or anaphylactoid reactions with cefazolin use in the last 6 months? We are assessing some cases as a group to look for common denominators as requested by our providers. Thanks ahead of time- would love to discuss if you have any suspicions.

Has anoyone seen an increase in anaphylaxis or anaphylatoid reactions with cefazolin use in the last 6 months? We are assessing some cases as a group to look for common denominators as requested by our providers. Thanks ahead of time- would love to discuss if you have any suspicions.

Happy New Year all! Is anyone having an increase in reported paclitaxel infusion related reactions? specifically with the PremierProRx or Anthenex manufacturers?

Thank you,
Amirah

Is anyone filtering IVIG doses that the pharmacy is drawing up and pooling into bags? We had an issue in the past with the silicone oil in syringes used to transfer the product to bags, creating particles. We started the practice of filtering when preparing and on administration but this is time consuming and we are curious what others are doing.

Thank you,
Shannon Manzi
Boston Children's Hospital